Bussmann Benjamin Mothibe, Dawkins Sam, Newton James, Cahill Thomas
Oxford Heart Centre, Oxford University Hospitals NHS Trust, Oxford, United Kingdom.
Burdon Sanderson Cardiac Science Centre, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom.
Front Cardiovasc Med. 2024 Dec 9;11:1487061. doi: 10.3389/fcvm.2024.1487061. eCollection 2024.
In patients undergoing transcatheter aortic valve implantation (TAVI), multi-valve disease is common and associated with worse outcomes. Despite multiple emerging transcatheter valve treatment options, no guidelines exist for the transcatheter treatment of multi-valve disease. We present a case of a 76-year-old patient with concomitant severe aortic valve stenosis and severe mitral valve stenosis who underwent concurrent TAVI and transcatheter mitral valve replacement. In this case report, we demonstrate the feasibility of concurrent double-valve transcatheter intervention to treat patients with multi-valve disease. We also highlight the role of the heart valve team to guide individual patient treatment strategies in the absence of clinical guidelines and the importance of multi-modality imaging to plan and execute the procedure.
在接受经导管主动脉瓣植入术（TAVI）的患者中，多瓣膜疾病很常见，且与更差的预后相关。尽管出现了多种经导管瓣膜治疗选择，但对于多瓣膜疾病的经导管治疗尚无指南。我们报告一例76岁患者，患有重度主动脉瓣狭窄和重度二尖瓣狭窄，同时接受了TAVI和经导管二尖瓣置换术。在本病例报告中，我们证明了同时进行双瓣膜经导管干预治疗多瓣膜疾病患者的可行性。我们还强调了心脏瓣膜团队在缺乏临床指南时指导个体患者治疗策略的作用，以及多模态成像在规划和实施手术中的重要性。
